Monopar Announces First Patient Dosed with its Novel Therapeutic Radiopharmaceutical MNPR-101-Lu
WILMETTE, Ill., Dec. 05, 2024 (GLOBE NEWSWIRE) -- Monopar Therapeutics Inc. (Nasdaq: MNPR), a clinical-stage biotechnology company focused on developing innovative treatments for patients with unmet medical needs, today announced the first patient ever dosed with MNPR-101-Lu. This novel therapeutic radiopharmaceutical combines MNPR-101, Monopar’s antibody that selectively targets...
【C.S】 Group Targets Global Pet Medication Market with Groundbreaking Taiwanofungus-Based New...
TAIPEI, Dec. 6, 2024 /PRNewswire/ -- Cordyceps Sunshine Biotech Holdings Co., Ltd. 【C.S】 Group, Taiwan's largest chain specializing in Taiwanofungus products, has officially announced its entry into the global pet medication market with a groundbreaking new drug. On November 30, 2024, the company co-hosted the "Taiwanofungus Fungal Technology and Pharmacological Research...
Coles Group Chooses Stibo Systems to Help Improve its Customer Experience...
MELBOURNE, Australia, Dec. 5, 2024 /PRNewswire/ -- Coles Group, a leading Australian retailer, announced the successful go-live of its master data management (MDM) solution in partnership...
Oculis Publishes Notifications of Transactions by Persons Discharging Managerial Responsibilities and...
ZUG, Switzerland, Nov. 29, 2024 (GLOBE NEWSWIRE) -- The attached notifications relate to the vesting of earnout shares and associated removal of restrictions on these ordinary shares.
Attachments
...
